[SCHEDULE 13G SEMILEDS CORPORATION (Name of Issuer) Common Stock, par value $0.0000056 per share (Title of Class of Securities) 816645 105 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing]
[Joint Filing Agreement This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument. [Remainder of this page has been left intentionally blank.] SAIF Partners IV L.P. Andrew Y. Yan Director of SAIF IV GP Capital Ltd., which is the General Partner of SAIF IV GP, L.P., which is] [January 30, 2016 The Board of Directors Sinovac Biotech Ltd. No. 39 Shangdi Xi Road, Haidian District, Beijing 100085 People’s Republic of China Dear Members of the Board of Directors Company Buyer Group Proposal Transaction 2 We believe that our Proposal provides a very attractive opportunity to the Company’s shareholders. Our Proposal represents a premium of approximately 23.11% to the] []
[Schedule 13G Forms CUSIP NO. 16950M107 13G 2 Page 1. NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY) GIC Private Limited (None ) 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* ¨ x (a) 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Singapore NUMBER OF SHARES]
[Press Releases Safe Harbor Statement 99.1 Press release regarding financial results for the fourth quarter and fiscal year ended December 31, 2015. CHANGYOU.COM LIMITED Jasmine Zhou, Chief Financial Officer Description 99.1 Press release regarding financial results for the fourth quarter and fiscal year ended December 31, 2015. Changyou Reports Fourth Quarter 2015 and Fiscal Year 2015 Unaudited Financial Results Beijing,]
[Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee The Board has formed a special committee consisting of three independent directors (the "Special Committee"), Mr. Simon Anderson, Mr. Yuk Lam Lo and Mr. Meng Mei, to consider the proposal. Mr. Simon Anderson is appointed as the chairman of the Special Committee.] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v430208_6k.htm FORM 6-K]
[Page 1.1 Announcement regarding final consideration amount for the transaction in relation to the disposal of telecommunications towers and related assets, dated January 29, 2016. A-1 our business and operating strategies and our ability to successfully execute these strategies; our network expansion and capital expenditure plans; our operations and business prospects; the expected benefit of any]
[Sinovac Biotech Announces Issuance of GMP Certificate for EV71 Vaccine BEIJING, January 28, 2016 - Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that the China Food and Drug Administration (“CFDA”) has issued the Good Manufacturing Practices (“GMP”) certificate to Sinovac for the Company's Enterovirus 71 ("EV71") vaccine. This marks the completion of the] []
[CNOOC Limited Jiewen Li]
